CHINA PHARMA HOLDINGS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3139 USD | -3.71% |
|
-1.16% | -48.12% |
| Apr. 01 | China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 23 | China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Sector
Pharmaceuticals
Calendar
2024-05-15
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -48.12% | 4.83M | |
| +26.20% | 653B | |
| +27.00% | 556B | |
| -6.66% | 354B | |
| +20.85% | 331B | |
| +2.32% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -5.98% | 144B |
- Stock Market
- Equities
- CPHI Stock
- News China Pharma Holdings, Inc.
- Top Midday Gainers
